QA: Esperion Therapeutics Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001434868_2026_Esperion_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001434868, Esperion Therapeutics Inc

  xvar xval
0 AssetsCurrent 462,570,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 338,000
3 remainder_Assets 2,978,000
4 LiabilitiesCurrent 300,810,000
5 LiabilitiesNoncurrent 9,392,000
6 remainder_Liabilities 457,649,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 166,029,160
9 ResearchAndDevelopmentExpense 49,026,154
10 remainder_Expenses 654,228,793
11 remainder_Revenues 426,307,966
12 remainder_NetIncome -46,448,876
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 465,886,000
1 Liabilities 767,851,000
2 Expenses 869,284,107
3 Revenues 426,307,966
4 StockholdersEquity -301,965,000
5 NetIncome -489,425,017
6 ComprehensiveNetIncome -489,425,017
7 BaseVar 1,287,888,974
8 EconomicCapitalRatiobeforeLimitedLiability -1.86
9 EconomicCapitalRatio 1.07

Edgar->Model Mapping

Feature Distribution

Change over Time